Lesen Sie hier weiter... |  Drucken |  PDF

Ähnliche Artikel

• INTELENCE(TM) (etravirine) Receives Positive Opinion From European Committee for Human Medicinal Products (CHMP) for Treatment of HIV
• Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union
• MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza
• PREZISTA(R) (darunavir) Receives Expanded Marketing Authorisation in the European Union for Treatment-Experienced Adults With HIV-1
• Bimatoprost / Timolol Fixed Combination Therapy Demonstrates Significantly Better IOP Control Over 12 Hours Compared to Latanoprost / Timolol Combination
• Sanofi-aventis is Complying With the EMEA's Recommendation to Temporarily Suspend the Marketing Authorisation of Acomplia(R) in Obese and Overweight Patients
• European Commission Announces Marketing Authorisation for 50mg Once Weekly Enbrel(R) for Patients With Moderate-to-Severe Psoriasis
• European Regulatory Agency Grants Orphan Status to Morphotek(R)'s Farletuzumab and MORAb-009
• Committee for Medicinal Products for Human Use (CHMP) Recommends Granting Marketing Authorisation for FIRMAGON(R) (degarelix) for Treatment of Prostate Cancer
• European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naïve Adults With HIV-1

Grüne Woche 2005: Ministerin Trauernicht genießt Sprotten unterm Funkturm

holsteinischeSpezialität in Eckernförde. INTELENCE(TM) (Etravirine) Receives Marketing Authorisation in the European Union for HIV Combination Therapy

Presseportal: Tibotec Pharmaceuticals Ltd. - Tibotec gibt Beginn der ...

Marketing Authorisation in the European Union for (TM) (Etravirine) Receives Marketing Authorisation in the European Union for HIV Combination Therapy

ots.at: das APA-OTS-Portal für multimediale Presseaussendungen

Part of Combination Therapy for Treatment-Naïve Adults With HIV-1 INTELENCE(TM) (Etravirine) Receives Marketing Authorisation in the European Union for HIV

Tibotec Pharmaceuticals Ltd. Pressemitteilungen News | PresseEcho.de

INTELENCE(TM) (Etravirine) Receives Marketing Authorisation in the European Union for HIV Combination Therapy anti-HIV medication INTELENCE(TM) (etravirine)

Presseportal.de - Tibotec Pharmaceuticals Ltd.

INTELENCE(TM) (Etravirine) Receives Marketing Authorisation in the European Union for HIV Combination Therapy INTELENCE(TM) (etravirine) Receives Positive